Capital Asset Advisory Services LLC Biomarin Pharmaceutical Inc Transaction History

Capital Asset Advisory Services LLC

  • $2.01 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$74.77 - $85.47 $190,140 - $217,350
-2,543 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$75.51 - $84.79 $192,021 - $215,620
2,543 New
2,543 $212,000
Q1 2021

May 13, 2021
SELL
$74.73 - $90.69 $158,128 - $191,900
-2,116 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$72.61 - $90.2 $153,642 - $190,863
2,116 New
2,116 $186,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email